Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Cytochrome P450 19A1 | Starlite/ChEMBL | References |
Homo sapiens | jun proto-oncogene | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | jun protein | Get druggable targets OG5_131442 | All targets in OG5_131442 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | Get druggable targets OG5_131442 | All targets in OG5_131442 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | Get druggable targets OG5_131442 | All targets in OG5_131442 |
Echinococcus multilocularis | jun protein | Get druggable targets OG5_131442 | All targets in OG5_131442 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_131442 | All targets in OG5_131442 |
Brugia malayi | bZIP transcription factor family protein | Get druggable targets OG5_131442 | All targets in OG5_131442 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Cytochrome P450 family protein | Cytochrome P450 19A1 | 508 aa | 448 aa | 20.8 % |
Dictyostelium discoideum | cytochrome P450 family protein | Cytochrome P450 19A1 | 508 aa | 465 aa | 21.5 % |
Drosophila melanogaster | Cytochrome P450-4d1 | Cytochrome P450 19A1 | 508 aa | 464 aa | 24.6 % |
Loa Loa (eye worm) | cytochrome P450 family protein | Cytochrome P450 19A1 | 508 aa | 450 aa | 21.1 % |
Dictyostelium discoideum | cytochrome P450 family protein | Cytochrome P450 19A1 | 508 aa | 473 aa | 18.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Fructose-bisphosphate aldolase | 0.0294 | 1 | 0.5 |
Brugia malayi | Pre-SET motif family protein | 0.003 | 0.0525 | 0.0217 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0209 | 0.6962 | 0.8104 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 1 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.1006 | 0.1557 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0036 | 0.0745 | 0.1125 |
Echinococcus multilocularis | zinc finger protein | 0.002 | 0.0154 | 0.015 |
Trypanosoma brucei | ISWI complex protein | 0.0015 | 0 | 0.5 |
Brugia malayi | follicle stimulating hormone receptor | 0.0254 | 0.857 | 1 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0021 | 0.0193 | 0.0126 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0101 | 0.3086 | 0.4989 |
Schistosoma mansoni | hypothetical protein | 0.0082 | 0.2404 | 0.3928 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0017 | 0.0063 | 0.0103 |
Plasmodium vivax | SET domain protein, putative | 0.003 | 0.0525 | 0.5 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.1006 | 0.1644 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.1141 | 0.1244 |
Echinococcus multilocularis | jun protein | 0.0101 | 0.3086 | 0.4989 |
Treponema pallidum | fructose-bisphosphate aldolase | 0.0294 | 1 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 1 | 1 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0023 | 0.0262 | 0.0327 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0186 | 0.6122 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 1 | 1 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0294 | 1 | 1 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0029 | 0.0486 | 0.0697 |
Mycobacterium leprae | Probable fructose bisphosphate aldolase Fba | 0.0144 | 0.4602 | 0.5 |
Echinococcus multilocularis | geminin | 0.0186 | 0.6122 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0015 | 0 | 0.5 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.003 | 0.0525 | 0.0763 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.003 | 0.0525 | 0.0858 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0047 | 0.1141 | 0.1864 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0918 | 0.0982 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 1 | 1 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.006 | 0.1603 | 0.2542 |
Echinococcus granulosus | jun protein | 0.0101 | 0.3086 | 0.4989 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0047 | 0.1141 | 0.1779 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0023 | 0.0262 | 0.0427 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0833 | 0.0881 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0254 | 0.857 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.003 | 0.0525 | 0.0858 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.2986 | 0.3419 |
Schistosoma mansoni | bromodomain containing protein | 0.0064 | 0.1732 | 0.283 |
Trypanosoma cruzi | ISWI complex protein | 0.0015 | 0 | 0.5 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0036 | 0.0745 | 0.1125 |
Schistosoma mansoni | jun-related protein | 0.0082 | 0.2404 | 0.3928 |
Brugia malayi | Bromodomain containing protein | 0.0075 | 0.2155 | 0.2199 |
Schistosoma mansoni | zinc finger protein | 0.002 | 0.0154 | 0.0252 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.1006 | 0.1557 |
Loa Loa (eye worm) | hypothetical protein | 0.0071 | 0.2001 | 0.2258 |
Onchocerca volvulus | 0.0238 | 0.8 | 1 | |
Brugia malayi | bZIP transcription factor family protein | 0.0101 | 0.3086 | 0.3331 |
Trypanosoma cruzi | ISWI complex protein | 0.0015 | 0 | 0.5 |
Echinococcus granulosus | zinc finger protein | 0.002 | 0.0154 | 0.015 |
Brugia malayi | hypothetical protein | 0.0043 | 0.1006 | 0.0802 |
Brugia malayi | Bromodomain containing protein | 0.0039 | 0.083 | 0.0588 |
Schistosoma mansoni | hypothetical protein | 0.0021 | 0.0193 | 0.0315 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.1006 | 0.1644 |
Brugia malayi | hypothetical protein | 0.008 | 0.2305 | 0.2381 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.006 | 0.1603 | 0.2542 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0186 | 0.6122 | 1 |
Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | 0.0144 | 0.4602 | 0.5 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0023 | 0.0262 | 0.0327 |
Onchocerca volvulus | 0.008 | 0.2305 | 0.238 | |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0047 | 0.1141 | 0.1779 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0017 | 0.0063 | 0.0103 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0101 | 0.3086 | 0.4989 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0987 | 0.1063 |
Brugia malayi | Pre-SET motif family protein | 0.0209 | 0.6962 | 0.8044 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 1 | 1 |
Echinococcus granulosus | geminin | 0.0186 | 0.6122 | 1 |
Mycobacterium ulcerans | fructose-bisphosphate aldolase | 0.0144 | 0.4602 | 0.5 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0047 | 0.1141 | 0.1864 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.003 | 0.0525 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 80 % | Antitrypanosomal activity against trypomastigotes of Trypanosoma cruzi Tulahuen infected in Swiss mouse model of chagas disease assessed as decrease in parasite level in blood at 100 mg/kg, ip administered 8 days after post infection qd for 5 days | ChEMBL. | 22536986 |
Cp (ADMET) | = 2.1 uM | Plasma concentration in Swiss mouse at 20 mg/kg, po after 1 hr | ChEMBL. | 22536986 |
EC50 (binding) | = 4.1 uM | In vitro inhibition of cytochrome P450 19A1 by rat ovarian microsomes incubated with [3H]-androstenedione and NADPH-generating system. | ChEMBL. | 3612685 |
EC50 (binding) | = 4.1 uM | In vitro inhibition of cytochrome P450 19A1 by rat ovarian microsomes incubated with [3H]-androstenedione and NADPH-generating system. | ChEMBL. | 3612685 |
IC50 (functional) | = 0.25 uM | DNDI: Inhibition of Chagas Disease parasite Trypanosoma cruzi (Tulahuen LacZ, Clone C4), in vitro. | ChEMBL. | No reference |
IC50 (functional) | = 0.35 uM | DNDI: Inhibition of Chagas Disease parasite Trypanosoma cruzi (Tulahuen LacZ, Clone C4), in vitro. | ChEMBL. | No reference |
IC50 (functional) | = 0.35 uM | Antitrypanosomal activity against trypomastigotes of Trypanosoma cruzi Tulahuen expressing the beta- galactosidase gene infected rat L6 cells after 96 hrs | ChEMBL. | 22536986 |
IC90 (functional) | = | DNDI: Inhibition of Chagas Disease parasite Trypanosoma cruzi (Tulahuen LacZ, Clone C4), in vitro. | ChEMBL. | No reference |
IC90 (functional) | = 0.56 uM | DNDI: Inhibition of Chagas Disease parasite Trypanosoma cruzi (Tulahuen LacZ, Clone C4), in vitro. | ChEMBL. | No reference |
Inhibition (ADMET) | = 66 % | Inhibition of CYP3A4/6 in human liver microsomes at 20 uM | ChEMBL. | 22536986 |
Potency (functional) | 6.1131 uM | PubChem BioAssay: Tox21. qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.5153 uM | PubChem BioAssay: Tox21. qHTS assay to identify small molecule agonists of the AP-1 signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 24.5412 uM | PubChem BioAssay: Tox21. qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of retinoid X receptor alpha signaling. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 34.9714 uM | PubChem BioAssay: Tox21. qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of farnesoid X receptor signaling. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PubChem BioAssay. qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 48.9662 uM | PubChem BioAssay: Tox21. qHTS assay to identify small molecule agonists of the NFkB signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 49.8242 uM | PubChem BioAssay: Tox21. qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of vitamin D receptor signaling. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 54.941 uM | PubChem BioAssay: Tox21. qHTS assay for small molecule activators of the heat shock response signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 68.5896 uM | PubChem BioAssay: Tox21. qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 69.7771 uM | PubChem BioAssay: Tox21. qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Trypanosoma cruzi | ChEMBL23 | 22536986 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.